Published June 29, 2017
| Version v1
Patent
Open
METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISTS AND BREAST CANCER
- 1. University of Chicago
Contributors
Patent applicant:
Description
Embodiments of the invention are directed to methods of determining the prognosis of a breast cancer patient by evaluating the activity of the glucocorticoid receptor in tumor cells. Other embodiment include methods of treating breast cancer cells, particularly, chemo-resistant cells, with a glucocorticoid receptor antagonist and an anticancer agent or compound.
Files
US20170182066.pdf
Files
(3.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:d2bb81d73e0050da0e1a2da574162cdd
|
3.9 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201715448827 A
- Patent number
- US 2017/0182066 A1
- Other
- oai:uchicago.tind.io:7943
Dates
- Patent filed
-
2017-03-03